1401031-28-4 Usage
Molecular structure
2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro[4.5]decan-9-yl]acetaldehyde has a complex molecular structure that includes a spiro decane ring fused with a pyridine ring and an aldehyde functional group.
Spiro compound
The presence of a spiro decane ring in the structure indicates that this compound belongs to the class of spiro compounds, which have been found to exhibit various biological activities.
Aldehyde functional group
The aldehyde group in the molecule suggests that it can undergo a range of chemical reactions, making it a versatile building block for the synthesis of more complex molecules.
Potential pharmaceutical applications
Due to its unique structure and the presence of biologically active components, 2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro[4.5]decan-9-yl]acetaldehyde has potential applications in the pharmaceutical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 1401031-28-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,0,1,0,3 and 1 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1401031-28:
(9*1)+(8*4)+(7*0)+(6*1)+(5*0)+(4*3)+(3*1)+(2*2)+(1*8)=74
74 % 10 = 4
So 1401031-28-4 is a valid CAS Registry Number.
1401031-28-4Relevant articles and documents
METHOD FOR PREPARING OXASPIROCYCLE DERIVATIVE, AND INTERMEDIATE THEREOF
-
Paragraph 0116; 0126, (2020/11/24)
A method for preparing an oxaspirocycle derivative and an intermediate thereof are described. The method reduces reaction steps, improves reaction yield, is simple and easy to operate, and is favorable for industrial large-scale production.
DEUTERATED COMPOUNDS FOR TREATING PAIN
-
, (2018/02/28)
The invention provides novel chemical compounds useful for treating pain or a related disease or disorder thereof, and pharmaceutical composition and methods of preparation and use thereof.
OPIOID RECEPTOR LIGANDS AND METHODS OF USING AND MAKING SAME
-
Page/Page column 28, (2012/10/08)
This application describes compounds that can act as opioid receptor ligands, which compounds can be used in the treatment of, for example, pain and pain related disorders.
